Log in to your Inderes Free account to see all free content on this page.

Coloplast

406.80 DKK

+0.69 %

Less than 1K followers

COLO B

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Dividend

Investor consensus

+0.69 %

-1.53 %

-15.46 %

-25.55 %

-30.22 %

-36.24 %

-53.67 %

-58.21 %

+767.38 %

Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Market cap

92.83B DKK

Turnover

32.79M DKK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

18.8.

2026

Interim report Q3'26

3.11.

2026

Annual report '26

1.12.

2026

General meeting '26

All

Press releases

ShowingAll content types

Regulatory press release5/12/2026, 5:30 AM

Coloplast A/S - Announcement no. 05/2026 - Interim Financial Report, H1 2025/26

Press release5/1/2026, 1:00 PM

Coloplast Receives Innovative Technology Contract from Vizient for Biatain® Silicone Fit

Regulatory press release4/23/2026, 5:50 PM

Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release4/22/2026, 5:08 PM

Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST

Regulatory press release3/12/2026, 4:01 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Regulatory press release3/11/2026, 6:25 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Regulatory press release3/10/2026, 2:39 PM

Coloplast A/S - Allocation of Share Options

Regulatory press release3/9/2026, 7:50 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Regulatory press release3/8/2026, 9:48 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Regulatory press release3/5/2026, 5:04 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Regulatory press release3/4/2026, 6:52 PM

Coloplast appoints Gavin Wood as new CEO

Regulatory press release2/11/2026, 2:36 PM

Coloplast A/S - Updated Financial Calendar 2025-26

Regulatory press release2/6/2026, 6:30 AM

Coloplast A/S - Interim Financial Report, Q1 2025/26

Press release1/26/2026, 12:02 PM

Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET

Regulatory press release12/18/2025, 2:00 PM

Coloplast announces changes to Executive Leadership Team

Regulatory press release12/4/2025, 4:50 PM

Coloplast A/S - Decisions at the Annual General Meeting 2025

Regulatory press release11/11/2025, 9:12 AM

Coloplast A/S - Notice of Annual General Meeting 2025

Regulatory press release11/4/2025, 6:32 AM

Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25

Regulatory press release11/4/2025, 6:31 AM

Coloplast A/S - Full-Year Financial Results 2024/25

Press release10/20/2025, 8:03 AM

Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on 4 Nov 2025 at 11.00 CET

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.